These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1640114)

  • 1. Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration.
    Merritt JA; Ball LA; Sielaff KM; Meltzer DM; Borden EC
    J Interferon Res; 1992 May; Spec No():7-16. PubMed ID: 1640114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration.
    Merritt JA; Ball LA; Sielaff KM; Meltzer DM; Borden EC
    J Interferon Res; 1986 Jun; 6(3):189-98. PubMed ID: 3745984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2',5'-oligoadenylate synthetase in interferon-alpha- and acyclovir-treated herpes simplex virus-infected cells.
    Taylor JL; Witt PL; Irizarry A; Tom P; O'Brien WJ
    J Interferon Cytokine Res; 1995 Jan; 15(1):27-30. PubMed ID: 7648430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoforms p69 and p100 of 2',5'-oligoadenylate synthetase induced differentially by interferons in vivo and in vitro.
    Witt PL; Marié I; Robert N; Irizarry A; Borden EC; Hovanessian AG
    J Interferon Res; 1993 Feb; 13(1):17-23. PubMed ID: 8454907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro induction of 2'-5' oligoadenylate synthetase by interferon-alpha in nodular non-Hodgkin's lymphoma and correlations with the clinical response.
    Ferbus D; Khosravi S; Dumont J; Billard C
    J Biol Regul Homeost Agents; 1990; 4(4):127-34. PubMed ID: 2096597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
    J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.
    Pawlotsky JM; Hovanessian AG; Roudot-Thoraval F; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
    Antimicrob Agents Chemother; 1996 Feb; 40(2):320-4. PubMed ID: 8834873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-5A synthetase activity in patients with metastatic carcinoma and its response to interferon treatment.
    Merritt JA; Meltzer DM; Ball LA; Borden EC
    Prog Clin Biol Res; 1985; 202():423-30. PubMed ID: 3832076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha.
    Merritt JA; Borden EC; Ball LA
    J Interferon Res; 1985; 5(1):191-8. PubMed ID: 3989336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.
    Millar BC; Bell JB
    Br J Cancer; 1995 Dec; 72(6):1525-30. PubMed ID: 8519671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein synthesis-dependent and -independent induction of p69 2'-5'-oligoadenylate synthetase by interferon-alpha.
    Yu F; Floyd-Smith G
    Cytokine; 1999 Oct; 11(10):744-50. PubMed ID: 10525312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of 2',5'-oligoadenylate synthetase by retinoic acid in two transformed human cell lines.
    Bourgeade MF; Besançon F
    Cancer Res; 1984 Nov; 44(11):5355-60. PubMed ID: 6435868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C is required for induction of 2',5'-oligoadenylate synthetases.
    Yu F; Floyd-Smith G
    Exp Cell Res; 1997 Aug; 234(2):240-8. PubMed ID: 9260891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic study of a human recombinant interferon (Re-IFN-alpha A) in cynomolgus monkeys by 2'-5' oligoadenylate synthetase assay.
    Bannai H; Tatsumi M; Kohase M; Onishi E; Yamazaki S
    Jpn J Med Sci Biol; 1985 Jun; 38(3):113-24. PubMed ID: 2999483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of human gamma interferon on cell growth, replication of virus and induction of 2'-5'oligoadenylate synthetase in three human lymphoblastoid cell lines and K562 cells.
    Tomita Y; Cantell K; Kuwata T
    Int J Cancer; 1982 Aug; 30(2):161-5. PubMed ID: 6182110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional differences in the promoters of the interferon-inducible (2'-5')A oligoadenylate synthetase and 6-16 genes in interferon-resistant Daudi cells.
    Guille MJ; Laxton CD; Rutherford MN; Williams BR; Kerr IM
    Eur J Biochem; 1994 Jan; 219(1-2):547-53. PubMed ID: 8307020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal dose of aerosolized interferon-alpha in human subjects: biological consequences and side-effects.
    Giosuè S; Casarini M; Ameglio F; Alemanno L; Saltini C; Bisetti A
    Eur Respir J; 1996 Jan; 9(1):42-6. PubMed ID: 8834332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal and interferon-induced 2',5'-oligoadenylate synthetase activity in human placental trophoblast and trophoblast-derived malignant cell lines.
    Dalsgaard AM; Aboagye-Mathiesen G; Justesen J; Zdravkovic M; Ebbesen P
    Placenta; 1995 Mar; 16(2):137-46. PubMed ID: 7540757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of HuIFN-gamma on 2',5'-oligoadenylate synthetase induction by HuIFN-alpha.
    Justesen J; Berg K
    J Interferon Res; 1986 Aug; 6(4):445-54. PubMed ID: 3095443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of 2',5'-oligoadenylate synthetase in freshly separated malignant cells from solid tumors. Variability in the susceptibility of interferon.
    Einhorn S; Vánky F; Grandér D; Willems JS
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1607-13. PubMed ID: 2448144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.